european medicines agency glp-1 vision loss recommendation november 2025 With the release of the World Health Organization's guideline on medications for obesity management, policymakers and clinicians are increasingly asking what global eligibility for these therapies looks like in practice. Co-authored Researchers move closer to matching

These gastrointestinal peptide hormones are not only effective in treating Type 2 diabetes, but they are also vital in weight management

This information can support a more informed conversation with your provider about whether additional precautions, slower dosing schedules, or alternative administration routes might benefit your individual treatment plan

They thereby exceed considerably their original purpose, which was to document that the drugs do not increase cardiovascular risk

The graphic below shows the degree of weight loss from each intervention, although the newer GLP-1s are likely to lead to similar weight loss to bariatric surgery